Document Type : Research Paper
Department of Pharmacognosy, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada-520010, AP, India
Department of Pharmaceutical Analysis, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada-520010, AP, India
Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura,Uttar Pradesh, India
Department of Pharmaceutical Analysis, V. V. Institute of Pharmaceutical Sciences, Gudlavalleru, Andhra Pradesh, India
Department of Pharmacy, K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur, Andhra Pradesh, India
Department of Pharmaceutics, V. V. Institute of Pharmaceutical Sciences, Gudlavalleru, Andhra Pradesh, India
Department of Pharmacology, Institute of Pharmaceutical Technology, Sri Padmavati Manila Viswavidyalayam, Tirupati, Andhra Pradesh, India
Department of Pharmaceutical Analysis, V. V. Institute of Pharmaceutical Sciences, Gudlavalleru, Andhra Pradesh, India.
Rhus succedanea (Anacardiaceae) was used to treat multiple human afflictions. Literary works demonstrate that it has many biological activities. Today's research aims to recognise Rhus succedanea phyto-derived anti-viral compounds against main protease and spike protein of the viral agent of COVID-19 (SARS-CoV-2), to gain insight into the molecular interactions. In the current study, 10 molecules taken from R. succedanea are analysed through docking, which is derived from the PubChem database. Docking experiments with Autodock vina and PyRx tools were conducted. AdmetSAR and DruLito servers were eventually used for drug-like prediction. Our research shows that the phytoconstituents from R. succedanea, namely, Amentoflavone, Rhoifolin and Agathisflavone acts against SARS CoV-2 main protease with the binding affinity of -9.3, -8.6 and -8.4 Kcal/mol; Hinokiflavone Robustaflavone and amentoflavone acts against the SARS-CoV-2 receptor-binding domain of spike protein with a binding affinity of -10.5, -10.4 and -10.1 Kcal/mol respectively. These phyto-compounds can use contemporary strategies to develop effective medicines from natural origins. The substances identified potential anti-viral as likely. However, In-vitro studies are even more necessary to assess their effectiveness versus SARS CoV-2.